["{\n\"step_by_step_thinking\": \"The question asks about the rationale for developing a killed vaccine for a newly identified virus that causes a severe respiratory illness. From the given documents, it is evident that killed vaccines are safer than live vaccines but have lower potency. Since the new illness is severe, a higher priority might be placed on safety rather than potency. Therefore, the most appropriate rationale for developing a killed vaccine would be to avoid the concern for reversion to virulence.\",\n\"answer_choice\": \"A\"\n}"]